NO308792B1 - Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat - Google Patents
Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparatInfo
- Publication number
- NO308792B1 NO308792B1 NO950849A NO950849A NO308792B1 NO 308792 B1 NO308792 B1 NO 308792B1 NO 950849 A NO950849 A NO 950849A NO 950849 A NO950849 A NO 950849A NO 308792 B1 NO308792 B1 NO 308792B1
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- valproic acid
- pharmaceutical
- derivatives
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/088,074 US5585358A (en) | 1993-07-06 | 1993-07-06 | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
PCT/US1994/007498 WO1995001956A1 (fr) | 1993-07-06 | 1994-07-06 | Derives d'amides d'acide valproique et d'acide 2-valproenoique et leur utilisation comme anticonvulsivants |
Publications (3)
Publication Number | Publication Date |
---|---|
NO950849D0 NO950849D0 (no) | 1995-03-03 |
NO950849L NO950849L (no) | 1995-04-26 |
NO308792B1 true NO308792B1 (no) | 2000-10-30 |
Family
ID=22209256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO950849A NO308792B1 (no) | 1993-07-06 | 1995-03-03 | Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat |
Country Status (23)
Country | Link |
---|---|
US (1) | US5585358A (fr) |
EP (1) | EP0659174B1 (fr) |
JP (1) | JP3856464B2 (fr) |
KR (1) | KR100362424B1 (fr) |
CN (2) | CN1106379C (fr) |
AT (1) | ATE176664T1 (fr) |
AU (1) | AU673766B2 (fr) |
CA (1) | CA2143636C (fr) |
CZ (1) | CZ288328B6 (fr) |
DE (1) | DE69416501T2 (fr) |
DK (1) | DK0659174T3 (fr) |
ES (1) | ES2131207T3 (fr) |
GR (1) | GR3030183T3 (fr) |
HK (1) | HK1055726A1 (fr) |
HU (1) | HU221968B1 (fr) |
IL (3) | IL133891A (fr) |
NO (1) | NO308792B1 (fr) |
NZ (1) | NZ269643A (fr) |
RO (1) | RO113461B1 (fr) |
RU (1) | RU2140904C1 (fr) |
SK (1) | SK282456B6 (fr) |
WO (1) | WO1995001956A1 (fr) |
ZA (1) | ZA944884B (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4326465A1 (de) * | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US6028102A (en) * | 1998-02-24 | 2000-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anticonvulsant drugs and pharmaceutical compositions thereof |
CZ2004266A3 (cs) | 2000-07-21 | 2005-02-16 | Teva Pharmaceutical Industries, Ltd. | Použití derivátů amidů kyseliny valproové a kyseliny 2-valproenové pro léčbu mánie při bipolární poruše |
US6323365B1 (en) * | 2000-07-28 | 2001-11-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Active derivative of valproic acid for the treatment of neurological and psychotic disorders and a method for their preparation |
WO2002013766A2 (fr) * | 2000-08-17 | 2002-02-21 | Teva Pharmaceutical Industries, Ltd. | Utilisation de derives d'amides d'acide valproique et d'amides d'acide 2-valproenique pour le traitement ou la prevention de la douleur et/ou des cephalees |
CA2427560C (fr) | 2000-11-01 | 2010-12-07 | Abbott Laboratories | Amides d'alkynyle et leurs applications therapeutiques |
US6521790B2 (en) | 2000-11-01 | 2003-02-18 | Abbott Laboratories | Alkynyl amides and their therapeutic applications |
PT1243262E (pt) | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
PT1243263E (pt) * | 2001-03-21 | 2003-03-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma |
US6958416B2 (en) * | 2001-06-26 | 2005-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents |
CA2477604A1 (fr) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation de la methylation de proteines et du phosphate des phosphoproteines |
AU2003266052B2 (en) * | 2002-09-04 | 2009-04-23 | Merck Frosst Canada Ltd | Cathepsin cysteine protease inhibitors |
WO2004071421A2 (fr) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Formule a liberation continue de n-(2-propylpentanoyl) glycinamide, et composes associes |
US20040176463A1 (en) * | 2003-02-05 | 2004-09-09 | Daniella Licht | Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
IL157751A0 (en) * | 2003-02-28 | 2004-03-28 | Yissum Res Dev Co | New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them |
AU2004294714B2 (en) * | 2003-12-02 | 2009-12-10 | Ucb Pharma Gmbh | Novel use of peptide compounds for treating central neuropathic pain |
US20060009384A1 (en) * | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
EP1579858A1 (fr) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Nouvelle utilisation de peptides pour le traitement de la neuropathie diabètique |
EP1734980A1 (fr) * | 2004-04-16 | 2006-12-27 | Schwarz Pharma Ag | Utilisation de composes peptidiques destinee a la prophylaxie et au traitement de maux de tete chroniques |
EP1604655A1 (fr) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Utilisation nouvelle de peptides pour le traitement de neuralgies trigeminales |
US20060025477A1 (en) * | 2004-07-22 | 2006-02-02 | Artman Linda D | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
CA2573125A1 (fr) * | 2004-08-27 | 2006-03-02 | Schwarz Pharma Ag | Nouvelle utilisation de composes peptidiques pour traiter la douleur liee au cancer des os, la douleur induite par la chimiotherapie et la therapie nucleosidique |
EP1642889A1 (fr) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Route de synthèse améliorée pour lacosamide |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
EP1843734A4 (fr) | 2005-02-03 | 2008-09-10 | Signum Biosciences Inc | Compositions et procedes pour l'amelioration de la fonction cognitive |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
EP1754476A1 (fr) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) pour le traitement de la myalgie, par exemple de la fibromyalgie |
WO2007028030A2 (fr) * | 2005-09-02 | 2007-03-08 | Picobella, Llc | Arn regulateurs oncogenes pour le diagnostic et la therapie |
US20070078083A1 (en) * | 2005-09-07 | 2007-04-05 | Braincells, Inc. | MODULATION OF NEUORGENESIS BY HDac INHIBITION |
US7459280B2 (en) * | 2006-02-27 | 2008-12-02 | Picobella, Llc | Methods for diagnosing and treating kidney cancer |
EP1873527A1 (fr) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Procédé d'identification des modulateurs CRMP |
EA027836B1 (ru) | 2006-06-15 | 2017-09-29 | ЮСиБи ФАРМА ГМБХ | Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение |
CN101466390B (zh) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
US20080267977A1 (en) * | 2007-04-26 | 2008-10-30 | Friedrich-Alexander University Of Erlangen-Nuremberg | Combined immunological agent and sensitizing agent for the treatment of cancer |
ES2326355B1 (es) * | 2008-02-25 | 2010-08-10 | Centro Atlantico Del Medicamento, S.A. | Acido 1-(di-n-propilacetilaminometil)-ciclohexilacetico. |
CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
EP2468261A1 (fr) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation de lacosamide |
CN115927191A (zh) | 2015-10-23 | 2023-04-07 | 优瑞科生物技术公司 | 抗体/t细胞受体嵌合构建体及其用途 |
AU2018258046A1 (en) | 2017-04-26 | 2019-12-12 | Eureka Therapeutics, Inc. | Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof |
CN112972449B (zh) * | 2019-12-18 | 2023-03-21 | 四川科瑞德制药股份有限公司 | 一种安全性高的药物组合物及其制备方法 |
WO2021245503A1 (fr) * | 2020-06-05 | 2021-12-09 | Cellix Bio Private Limited | Procédé de préparation de dérivés d'éflornithine et leurs sels pharmaceutiquement acceptables |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3050800C2 (fr) * | 1979-03-22 | 1989-06-22 | Continental Pharma Inc., Bruessel/Bruxelles, Be | |
FR2489319A1 (fr) * | 1980-08-27 | 1982-03-05 | Clin Midy | Derives de l'acide amino-4 butyrique et les medicaments, actifs notamment sur le systeme nerveux central, en contenant |
BE885303A (fr) * | 1980-09-19 | 1981-03-19 | Continental Pharma | Glycinamides |
FI832935A (fi) * | 1982-08-20 | 1984-02-21 | Midit | Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar |
US4913906B1 (en) * | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
IT1190133B (it) * | 1986-06-19 | 1988-02-10 | Chiesi Farma Spa | Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche |
FR2620447B1 (fr) * | 1987-09-15 | 1990-01-26 | Sanofi Sa | Procede de preparation du di-n-propylacetonitrile |
-
1993
- 1993-07-06 US US08/088,074 patent/US5585358A/en not_active Expired - Lifetime
-
1994
- 1994-07-05 IL IL13389194A patent/IL133891A/xx not_active IP Right Cessation
- 1994-07-05 IL IL11021694A patent/IL110216A/xx not_active IP Right Cessation
- 1994-07-06 SK SK395-95A patent/SK282456B6/sk not_active IP Right Cessation
- 1994-07-06 ZA ZA944884A patent/ZA944884B/xx unknown
- 1994-07-06 ES ES94923915T patent/ES2131207T3/es not_active Expired - Lifetime
- 1994-07-06 DE DE69416501T patent/DE69416501T2/de not_active Expired - Lifetime
- 1994-07-06 CN CN94190471A patent/CN1106379C/zh not_active Expired - Fee Related
- 1994-07-06 NZ NZ269643A patent/NZ269643A/en not_active IP Right Cessation
- 1994-07-06 JP JP50409795A patent/JP3856464B2/ja not_active Expired - Fee Related
- 1994-07-06 RO RO95-00475A patent/RO113461B1/ro unknown
- 1994-07-06 RU RU95108243A patent/RU2140904C1/ru not_active IP Right Cessation
- 1994-07-06 EP EP94923915A patent/EP0659174B1/fr not_active Expired - Lifetime
- 1994-07-06 WO PCT/US1994/007498 patent/WO1995001956A1/fr active IP Right Grant
- 1994-07-06 HU HU9500503A patent/HU221968B1/hu not_active IP Right Cessation
- 1994-07-06 CZ CZ1995853A patent/CZ288328B6/cs not_active IP Right Cessation
- 1994-07-06 AU AU73968/94A patent/AU673766B2/en not_active Ceased
- 1994-07-06 DK DK94923915T patent/DK0659174T3/da active
- 1994-07-06 KR KR1019950700884A patent/KR100362424B1/ko not_active IP Right Cessation
- 1994-07-06 CA CA002143636A patent/CA2143636C/fr not_active Expired - Fee Related
- 1994-07-06 AT AT94923915T patent/ATE176664T1/de not_active IP Right Cessation
- 1994-07-06 CN CNB021053588A patent/CN100457720C/zh not_active Expired - Fee Related
-
1995
- 1995-03-03 NO NO950849A patent/NO308792B1/no not_active IP Right Cessation
-
1999
- 1999-05-10 GR GR990401269T patent/GR3030183T3/el unknown
-
2000
- 2000-01-05 IL IL13389100A patent/IL133891A0/xx unknown
-
2003
- 2003-11-10 HK HK03108127.6A patent/HK1055726A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308792B1 (no) | Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat | |
CA2075876A1 (fr) | Nouveaux derives d'arylethylamines, leurs procedes de preparation et lescompositions pharmaceutiques qui les contiennent | |
SI0659747T1 (en) | Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them | |
WO2002007677A3 (fr) | Utilisation de derives d'acide valproique et d'amides d'acide 2-valproenique pour le traitement de la manie en cas de desordre bipolaire | |
ES8600202A1 (es) | Procedimiento de preparacion de nuevos derivados dietilaminoalcoxibenzoles y de sus sales de adicion acidas y amonicas cuaternarias | |
AU558261B2 (en) | Dialkylaminoalkyoxybenzylalcohol derivatives | |
IL108856A0 (en) | Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
HUT53103A (en) | Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients | |
AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |